Hans Biomed Corporation. The Company's principal activity is providing biotechnology products. It provides three categories of products: products for skin implant, products for bone implant and silicone products. The products for skin implant include SureDerm, which is acellular human dermis used for the repair or replacement of damaged soft tissue; GPS, which is glycerol preserved skin used as wound dressing, and Sheba, which is micronized injectable human tissue for the correction of wrinkles and dents on the face. The products for bone implant include SureFuse, which is mixture of demineralized bone matrix (DBM) used for forming normal healthy bone by stimulation of mesenchymal cell proliferation; ExFuse, which is DBM to which cancellous bone chip is added, and SureOss, which is made of freeze dried cortical bone and helps bone regeneration. The silicone products include treatments for scars, and silicone materials for facial implant, nasal implant, breast implant and others.
Headquarters
Room 807 Sk Bldg, 16-4 Seongsu 1Ga 2-Dong, Seongdong-Gu
Seoul; Seoul;
Postal Code: 133-822
Contact Details: Purchase the Hans Bio Med Corporation report to view the information.
Website: http://www.hansbiomed.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service